A bibliometric analysis of atezolizumab in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) is a highly prevalent primary liver cancer, accounting for over 90% of all liver cancer cases worldwide and ranking as the third leading cause of cancer-related deaths. The emergence of molecular targeted therapies has completely transformed the tre...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer
2025-10-01
|
| Schriftenreihe: | Discover Oncology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/s12672-025-03447-6 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|